Avricore Health (AVCRF) Cash from Financing Activities (2014 - 2024)

Avricore Health has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $28662.4 for Q3 2024.

• In Q3 2024, Cash from Financing Activities changed N/A year-over-year to $28662.4; the TTM figure through Sep 2024 stood at $8178.7 (down 95.69% YoY), while the FY2024 annual figure was $41340.6, up 31.24% from the prior year.
• Cash from Financing Activities grew to $28662.4 in Q3 2024, from -$9797.3 in the prior quarter.
• Over the last five years, Cash from Financing Activities for AVCRF reached as high as $2.0 million in Q1 2021 and fell as low as -$10686.4 in Q1 2024.
• The 5-year median for Cash from Financing Activities is $28755.3 (2020), against an average of $238130.2.
• Annual changes were most pronounced in 2021 — Cash from Financing Activities soared 29339.31% — and 2024, when it plunged 187.74%.
• A 5-year view of Cash from Financing Activities shows it stood at $473420.0 in 2020, then plunged by 87.11% to $61042.5 in 2021, then jumped by 159.33% to $158302.7 in 2022, then tumbled by 92.95% to $11166.8 in 2023, then surged by 156.68% to $28662.4 in 2024.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $28662.4, -$9797.3, and -$10686.4 for Q3 2024, Q2 2024, and Q1 2024 respectively.